Prediction of future Alzheimer’s disease dementia using plasma phospho-tau combined with other accessible measures
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prediction of future Alzheimer’s disease dementia using plasma phospho-tau combined with other accessible measures
Authors
Keywords
-
Journal
NATURE MEDICINE
Volume 27, Issue 6, Pages 1034-1042
Publisher
Springer Science and Business Media LLC
Online
2021-05-25
DOI
10.1038/s41591-021-01348-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia
- (2020) Shorena Janelidze et al. NATURE MEDICINE
- Brief Cognitive Tests Used in Primary Care Cannot Accurately Differentiate Mild Cognitive Impairment from Subjective Cognitive Decline
- (2020) Ferdinando Petrazzuoli et al. JOURNAL OF ALZHEIMERS DISEASE
- Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts
- (2020) Thomas K Karikari et al. LANCET NEUROLOGY
- The implications of different approaches to define AT(N) in Alzheimer disease
- (2020) Niklas Mattsson-Carlgren et al. NEUROLOGY
- The age-related effect on cognitive performance in cognitively healthy elderly is mainly caused by underlying AD pathology or cerebrovascular lesions: implications for cutoffs regarding cognitive impairment
- (2020) Emma Borland et al. Alzheimers Research & Therapy
- Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer’s disease and PET amyloid-positive patient identification
- (2020) Nicolas R. Barthélemy et al. Alzheimers Research & Therapy
- Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders
- (2020) Antoine Leuzy et al. JAMA Neurology
- Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer’s disease
- (2020) Niklas Mattsson-Carlgren et al. Science Advances
- Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders
- (2020) Sebastian Palmqvist et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer’s disease
- (2020) Nicolas R. Barthélemy et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Longitudinal plasma p-tau217 is increased in early stages of Alzheimer’s disease
- (2020) Niklas Mattsson-Carlgren et al. BRAIN
- Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer’s Disease Neuroimaging Initiative
- (2020) Thomas K. Karikari et al. MOLECULAR PSYCHIATRY
- Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
- (2020) Niklas Mattsson-Carlgren et al. Nature Communications
- Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease
- (2019) Oliver Preische et al. NATURE MEDICINE
- Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia
- (2019) Gil D. Rabinovici et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Determining clinically meaningful decline in preclinical Alzheimer disease
- (2019) Philip S. Insel et al. NEUROLOGY
- Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease–Related β-Amyloid Status
- (2019) Sebastian Palmqvist et al. JAMA Neurology
- Staging β-Amyloid Pathology With Amyloid Positron Emission Tomography
- (2019) Niklas Mattsson et al. JAMA Neurology
- Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
- (2019) Sebastian Palmqvist et al. EMBO Molecular Medicine
- Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography
- (2018) Michelle M. Mielke et al. Alzheimers & Dementia
- CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts
- (2018) Oskar Hansson et al. Alzheimers & Dementia
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Tau Kinetics in Neurons and the Human Central Nervous System
- (2018) Chihiro Sato et al. NEURON
- Accurate risk estimation of β-amyloid positivity to identify prodromal Alzheimer's disease: Cross-validation study of practical algorithms
- (2018) Sebastian Palmqvist et al. Alzheimers & Dementia
- The Montreal Cognitive Assessment: Normative Data from a Large Swedish Population-Based Cohort
- (2017) Emma Borland et al. JOURNAL OF ALZHEIMERS DISEASE
- Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity
- (2017) Sebastian Palmqvist et al. Nature Communications
- CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease
- (2016) Shorena Janelidze et al. Annals of Clinical and Translational Neurology
- Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study
- (2016) Magnus Gisslén et al. EBioMedicine
- Alzheimer’s Disease Neuroimaging Initiative 2 Clinical Core: Progress and plans
- (2015) Paul S. Aisen et al. Alzheimers & Dementia
- Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia
- (2015) Willemijn J. Jansen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Accuracy of Brain Amyloid Detection in Clinical Practice Using Cerebrospinal Fluid β-Amyloid 42
- (2014) Sebastian Palmqvist et al. JAMA Neurology
- Amyloid deposition, hypometabolism, and longitudinal cognitive decline
- (2012) Susan M. Landau et al. ANNALS OF NEUROLOGY
- Comparison of Brief Cognitive Tests and CSF Biomarkers in Predicting Alzheimer’s Disease in Mild Cognitive Impairment: Six-Year Follow-Up Study
- (2012) Sebastian Palmqvist et al. PLoS One
- Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI
- (2011) Jon B. Toledo et al. ACTA NEUROPATHOLOGICA
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- Cognitive Impairment Questionnaire (CIMP-QUEST): reported topographic symptoms in MCI and dementia
- (2010) R. Åstrand et al. ACTA NEUROLOGICA SCANDINAVICA
- The Mayo Clinic Study of Aging: Design and Sampling, Participation, Baseline Measures and Sample Characteristics
- (2008) Rosebud O. Roberts et al. NEUROEPIDEMIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now